Company: QXO-PB
Filing Date: 2025-05-22
Form Type: 424B5
Source: 0001104659-25-052056
Chunk: 17

Company: QXO, Inc.
Filing Date: 2025-05-22
Form: 424B5
Chunk 17
---
 and expenses related to the Transactions; (iv) the consummation of the Beacon Acquisition and (v) the consummation of this offering of Common Stock and the Depositary Shares Offering (assuming no exercise of the underwriters’ options to purchase additional shares) and the application of net proceeds as described under “Use of Proceeds.”

#### Corporate Information
Our principal executive offices are located at Five American Lane, Greenwich, Connecticut 06831. Our telephone number is (888) 998-6000. Our website is www.qxo.com. The information on our website is not incorporated by reference into this prospectus supplement or the accompanying prospectus (except for SEC reports that are expressly incorporated by reference herein).

<div align='center'>S-6</div>

TABLE OF CONTENTS

### THE OFFERING
Issuer

QXO, Inc.

Securities offered

48,484,849 shares of Common Stock.

Option to purchase additional shares of Common Stock

We have granted the underwriters an option to purchase up to 7,272,727 additional shares of Common Stock at the public offering price less underwriting discounts and commissions. The underwriters may exercise this option at any time within 30 days from the date of this prospectus supplement.

Concurrent Depositary Shares Offering

Concurrently with this offering of our Common Stock, we are offering 10,000,000 Depositary Shares, pursuant to a separate prospectus supplement. We have also granted the underwriters of the Depositary Shares Offering a 30-day option to purchase up to 1,500,000 additional Depositary Shares, solely to cover over-allotments, if any. The closing of this offering is not conditioned upon the closing of the Depositary Shares Offering, and the closing of the Depositary Shares Offering is not conditioned upon the closing of this offering, so it is possible that this offering occurs and the Depositary Shares Offering does not occur, or vice versa. We cannot assure you that the Depositary Shares Offering will be completed on the terms described herein, or at all. See the section titled “Concurrent Depositary Shares Offering.”

Shares of Common Stock to be outstanding after this 
 offering

570,992,779 shares of Common Stock (or 578,265,506 shares of Common Stock if the underwriters exercise in full their option to purchase additional shares).

Use of proceeds

We expect to receive net proceeds from this offering of approximately $776.2 million (or approximately $892.8 million if the underwriters exercise in full